Veritas Pharma Inc.

A discovery and IP development company, advancing the science behind medical Cannabis

Company Overview

Recent News on Veritas Pharma Inc.


“Cannevert scientist accepted to attend Bedrocan’s Masterclass on medicinal cannabis in Leiden, The Netherlands”

Latest News

Investors Presentation

Dedicated to discovering new cannabis cultivars for disease-specific actions

View PDF

In The Media

“Here’s why Veritas Pharma Inc is one of the most exciting stocks in medical marijuana right now”

Read More

About Veritas Pharma

In an industry projected to have substantial growth within next few years, Veritas is among the first to apply a comprehensive scientific approach behind medical marijuana claims. Our mission is to develop the most effective proprietary cannabis strains for specific disease conditions, and to provide doctors and patients with conclusive scientific evidence to recommend and use medical marijuana with confidence.

This approach is combined with concise market entry approach: Veritas, through its wholly owned subsidiary Sechelt Organic Marijuana Inc., aims to become a license producer and has had an ACMPR application pending with Health Canada since July 4th, 2014.

Veritas Approach

The Veritas Newsletter

Enter your email to receive news alerts and updates from Veritas Pharma.

You have Successfully Subscribed!